During the past decade, California Retina Consultants conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 13 clinical trials were completed, i.e. on average, 40.6% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 10 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "California Retina Consultants" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "California Retina Consultants" with 7 trials sponsored, "Apellis Pharmaceuticals, Inc." with 4 trials sponsored, "Clearside Biomedical, Inc." with 3 trials sponsored and "Genentech, Inc." with 3 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "California Retina Consultants" #1 collaborator was "Genentech, Inc." with 4 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "California Retina Consultants" are "Geographic Atrophy" (10 trials), "Diabetic Macular Edema" (9 trials), "Macular Degeneration, Age-Related" (3 trials), "Age Related Macular Degeneration" (2 trials) and "Central Retinal Vein Occlusion" (2 trials). Many other conditions were trialed in "California Retina Consultants" in a lesser frequency.

Most popular intervention types in "California Retina Consultants" are "Drug" (35 trials), "Other" (9 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (10 trials), "Aflibercept" (4 trials), "Faricimab" (4 trials), "Ranibizumab" (4 trials) and "KSI-301" (3 trials). Other intervention names were less common.

The vast majority of trials in "California Retina Consultants" are 38 trials for "All" genders.

Currently, there are NaN active trials in "California Retina Consultants". undefined are not yet recruiting, 2 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in California Retina Consultants, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in California Retina Consultants, 7 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".